Although human thyroid cancer cells with RAS mutations or PTEN loss show strong ß -catenin nuclear localization, there is only a modest activation of the ß-cat/TCF reporter relative to cells without ß-catenin in the nucleus (Figure 2). This evidence concerns the gene PTEN and thyroid cancer.